Artigos de revistas sobre o tema "Vaccins ADN"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Vaccins ADN".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Ladenheim, Ruth. "Les vaccins à ADN nu". Biofutur 1995, n.º 145 (maio de 1995): 14. http://dx.doi.org/10.1016/0294-3506(95)80125-1.
Texto completo da fontePitard, Bruno. "Nanotaxi® pour les vaccins ARN et ADN". médecine/sciences 35, n.º 10 (outubro de 2019): 749–52. http://dx.doi.org/10.1051/medsci/2019143.
Texto completo da fonteQUENTEL, C., M. BREMONT e H. POULIQUEN. "La vaccination chez les poissons d’élevage". INRAE Productions Animales 20, n.º 3 (7 de setembro de 2007): 233–38. http://dx.doi.org/10.20870/productions-animales.2007.20.3.3463.
Texto completo da fonteParis, Robert, Robert A. Kuschner, Leonard Binn, Stephen J. Thomas, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Robert T. Bailer, Nancy Sullivan e Richard A. Koup. "Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors". Clinical and Vaccine Immunology 21, n.º 5 (12 de março de 2014): 783–86. http://dx.doi.org/10.1128/cvi.00011-14.
Texto completo da fonteHarro, Clayton, Xiao Sun, Jon E. Stek, Randi Y. Leavitt, Devan V. Mehrotra, Fubao Wang, Andrew J. Bett et al. "Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults". Clinical and Vaccine Immunology 16, n.º 9 (15 de julho de 2009): 1285–92. http://dx.doi.org/10.1128/cvi.00144-09.
Texto completo da fonteBeaty, Shannon, Natalie Collins, Nicos Karasavvas, Robert Kuschner, Jun Hang, Anima Adhikari, Irina Maljkovic Berry et al. "A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults". Vaccines 11, n.º 6 (12 de junho de 2023): 1091. http://dx.doi.org/10.3390/vaccines11061091.
Texto completo da fonte邱南昌, 邱南昌, e 張濱璿 Nan-Chang Chiu. "臺灣預防接種受害救濟制度與COVID-19疫苗". 月旦醫事法報告 67, n.º 67 (maio de 2022): 050–61. http://dx.doi.org/10.53106/241553062022050067004.
Texto completo da fonteHalstead, Scott B., e Leah Katzelnick. "COVID-19 Vaccines: Should We Fear ADE?" Journal of Infectious Diseases 222, n.º 12 (12 de agosto de 2020): 1946–50. http://dx.doi.org/10.1093/infdis/jiaa518.
Texto completo da fonteYılmaz, Engin. "Aşı Teknolojisinde Yeni Umutlar: mRNA Aşıları". Mikrobiyoloji Bulteni 55, n.º 2 (19 de abril de 2021): 265–84. http://dx.doi.org/10.5578/mb.20219912.
Texto completo da fonteAppledorn, Daniel M., Yasser A. Aldhamen, Sarah Godbehere, Sergey S. Seregin e Andrea Amalfitano. "Sublingual Administration of an Adenovirus Serotype 5 (Ad5)-Based Vaccine Confirms Toll-Like Receptor Agonist Activity in the Oral Cavity and Elicits Improved Mucosal and Systemic Cell-Mediated Responses against HIV Antigens despite Preexisting Ad5 Immunity". Clinical and Vaccine Immunology 18, n.º 1 (17 de novembro de 2010): 150–60. http://dx.doi.org/10.1128/cvi.00341-10.
Texto completo da fonteGuzmán-Martínez, Oscar, Kathia Guardado, Elsa Ladrón de Guevara, Saturnino Navarro, Crescencio Hernández, Roberto Zenteno-Cuevas e Hilda Montero. "IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population". Vaccines 9, n.º 9 (8 de setembro de 2021): 999. http://dx.doi.org/10.3390/vaccines9090999.
Texto completo da fonteTang, Jinyi, Cong Zeng, Thomas M. Cox, Chaofan Li, Young Min Son, In Su Cheon, Supriya Behl et al. "Respiratory humoral and cellular immune responses following COVID-19 mRNA vaccination". Journal of Immunology 208, n.º 1_Supplement (1 de maio de 2022): 65.22. http://dx.doi.org/10.4049/jimmunol.208.supp.65.22.
Texto completo da fonteThiele, Sonja, Aljona Borschewski, Judit Küchler, Marc Bieberbach, Sebastian Voigt e Bernhard Ehlers. "Molecular Analysis of Varicella Vaccines and Varicella-Zoster Virus from Vaccine-Related Skin Lesions". Clinical and Vaccine Immunology 18, n.º 7 (11 de maio de 2011): 1058–66. http://dx.doi.org/10.1128/cvi.05021-11.
Texto completo da fonteBroderick, Michael P., Sandra Romero-Steiner, Gowrisankar Rajam, Scott E. Johnson, Andrea Milton, Ellie Kim, Lisa J. Choi et al. "Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone". Clinical and Vaccine Immunology 23, n.º 8 (8 de junho de 2016): 672–80. http://dx.doi.org/10.1128/cvi.00267-16.
Texto completo da fonteBraucher, Douglas R., Jamie N. Henningson, Crystal L. Loving, Amy L. Vincent, Eun Kim, Julia Steitz, Andrea A. Gambotto e Marcus E. Kehrli. "Intranasal Vaccination with Replication-Defective Adenovirus Type 5 Encoding Influenza Virus Hemagglutinin Elicits Protective Immunity to Homologous Challenge and Partial Protection to Heterologous Challenge in Pigs". Clinical and Vaccine Immunology 19, n.º 11 (29 de agosto de 2012): 1722–29. http://dx.doi.org/10.1128/cvi.00315-12.
Texto completo da fonteWang, Anqi. "Advantages And Disadvantages of Different COVID-19 Vaccines". Highlights in Science, Engineering and Technology 45 (18 de abril de 2023): 319–24. http://dx.doi.org/10.54097/hset.v45i.7483.
Texto completo da fonteMuñoz-Valle, José Francisco, Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Cristian Oswaldo Hernández-Ramírez, Saúl Alberto Díaz-Pérez, Christian Johana Baños-Hernández, Francisco Javier Turrubiates-Hernández, Alejandra Natali Vega-Magaña e Jorge Hernández-Bello. "Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study". Vaccines 10, n.º 3 (5 de março de 2022): 400. http://dx.doi.org/10.3390/vaccines10030400.
Texto completo da fonteChondronasiou, Dafni, Tracy-Jane Eisden, Anita Stam, Qiana Matthews, Mert Icyuz, Erik Hooijberg, Igor Dmitriev, David Curiel, Tanja de Gruijl e Rieneke van de Ven. "Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs". Vaccines 6, n.º 3 (18 de julho de 2018): 42. http://dx.doi.org/10.3390/vaccines6030042.
Texto completo da fonteCassier, Maurice. "Producing, Controlling, and Stabilizing Pasteur's Anthrax Vaccine: Creating a New Industry and a Health Market". Science in Context 21, n.º 2 (junho de 2008): 253–78. http://dx.doi.org/10.1017/s0269889708001713.
Texto completo da fonteSun, Haiyan, Dhiraj Acharya, Amber M. Paul, Huafang Lai, Junyun He, Fengwei Bai e Qiang Chen. "Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus". Vaccines 11, n.º 2 (17 de janeiro de 2023): 197. http://dx.doi.org/10.3390/vaccines11020197.
Texto completo da fonteDeng, Sheng-Qun, Xian Yang, Yong Wei, Jia-Ting Chen, Xiao-Jun Wang e Hong-Juan Peng. "A Review on Dengue Vaccine Development". Vaccines 8, n.º 1 (2 de fevereiro de 2020): 63. http://dx.doi.org/10.3390/vaccines8010063.
Texto completo da fonteMcFarland, Elizabeth J., Ruth A. Karron, Petronella Muresan, Coleen K. Cunningham, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva et al. "Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children". Journal of Infectious Diseases 221, n.º 12 (1 de fevereiro de 2020): 2050–59. http://dx.doi.org/10.1093/infdis/jiaa049.
Texto completo da fonteWilson, Nancy A., Brandon F. Keele, Jason S. Reed, Shari M. Piaskowski, Caitlin E. MacNair, Andrew J. Bett, Xiaoping Liang et al. "Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge". Journal of Virology 83, n.º 13 (29 de abril de 2009): 6508–21. http://dx.doi.org/10.1128/jvi.00272-09.
Texto completo da fonteWhelan, Allison M. "Lowering the Age of Consent: Pushing Back against the Anti-Vaccine Movement". Journal of Law, Medicine & Ethics 44, n.º 3 (2016): 462–73. http://dx.doi.org/10.1177/1073110516667942.
Texto completo da fonteAli, Muhammad Zahid, Yousra Anwar, Adil Abbas, Noor Ul Ain, Zainab Khalid, Arooj Sattar, Muhammad Usman, Arzoo Nazir e Shah Zeb. "Recent Advances in Vaccine Technology for Viral Infection Management: A Spotlight on Next-Generation Vaccines and Nucleic Acid-Based Platforms". Pakistan Journal of Medical and Health Sciences 17, n.º 5 (23 de junho de 2023): 261–66. http://dx.doi.org/10.53350/pjmhs2023175261.
Texto completo da fonteCrum, Tommie, Kirsten Mooney e Birendra R. Tiwari. "Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases". F1000Research 10 (7 de dezembro de 2021): 652. http://dx.doi.org/10.12688/f1000research.51160.2.
Texto completo da fonteCrum, Tommie, Kirsten Mooney e Birendra R. Tiwari. "Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases". F1000Research 10 (26 de julho de 2021): 652. http://dx.doi.org/10.12688/f1000research.51160.1.
Texto completo da fonteMatsegora, N. А., e A. V. Kaprosh. "Current state of developments and research of new candidate vaccines against tuberculosis (literature review)". Tuberculosis, Lung Diseases, HIV Infection, n.º 2 (17 de junho de 2022): 48–57. http://dx.doi.org/10.30978/tb-2022-2-48.
Texto completo da fonteLiang, Xiaoping, Danilo R. Casimiro, William A. Schleif, Fubao Wang, Mary-Ellen Davies, Zhi-Qiang Zhang, Tong-Ming Fu et al. "Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys". Journal of Virology 79, n.º 19 (1 de outubro de 2005): 12321–31. http://dx.doi.org/10.1128/jvi.79.19.12321-12331.2005.
Texto completo da fonteLau, Chin Shern, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu e Tar Choon Aw. "Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore". Antibodies 11, n.º 2 (27 de maio de 2022): 38. http://dx.doi.org/10.3390/antib11020038.
Texto completo da fonteSteinhoff, Mark C., George F. Reed, Michael D. Decker, Kathryn M. Edwards, Janet A. Englund, Michael E. Pichichero, Margaret B. Rennels, Edwin L. Anderson, Maria A. Deloria e Bruce D. Meade. "A Randomized Comparison of Reactogenicity and Immunogenicity of Two Whole-Cell Pertussis Vaccines". Pediatrics 96, n.º 3 (1 de setembro de 1995): 567–70. http://dx.doi.org/10.1542/peds.96.3.567.
Texto completo da fonteKim, Ji Yeun, So Yun Lim, Soonju Park, Ji-Soo Kwon, Seongman Bae, Ji Young Park, Hye Hee Cha et al. "Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period". Journal of Infectious Diseases 225, n.º 5 (25 de novembro de 2021): 777–84. http://dx.doi.org/10.1093/infdis/jiab579.
Texto completo da fonteCasimiro, Danilo R., Aimin Tang, Ling Chen, Tong-Ming Fu, Robert K. Evans, Mary-Ellen Davies, Daniel C. Freed et al. "Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene". Journal of Virology 77, n.º 13 (1 de julho de 2003): 7663–68. http://dx.doi.org/10.1128/jvi.77.13.7663-7668.2003.
Texto completo da fonteIyasu Angani, Dereja. "Veterinary vaccine development: The helical project". Insights in Veterinary Science 4, n.º 1 (28 de agosto de 2020): 042–47. http://dx.doi.org/10.29328/journal.ivs.1001025.
Texto completo da fonteKang, Chang-Yuil, Soojeong Chang, Kwang-Soo Shin, In Kyung Jung, Hyemin Park, Jonghan Oh, Seowoo Park, Jieun Shin e Jong Heon Kim. "Development of broadly protective COVID-19 vaccine against up-to-date variants based on adenovirus type 5/35 vector platform." Journal of Immunology 210, n.º 1_Supplement (1 de maio de 2023): 159.06. http://dx.doi.org/10.4049/jimmunol.210.supp.159.06.
Texto completo da fonteKawile, Leo, Keli Fisher e Mia Noergaard. "An Exploration of the Relationship Between Vaccine Knowledge and Vaccine Willingness". Psi Beta Research Journal - Brief Reports 3, n.º 1 (12 de outubro de 2023): 56–60. http://dx.doi.org/10.54581/luzr1510.
Texto completo da fonteCamacho, Luiz Antonio Bastos, Marcos da Silva Freire, Maria da Luz Fernandes Leal, Savitri Gomes de Aguiar, Jussara Pereira do Nascimento, Takumi Iguchi, José de Azevedo Lozana e Roberto Henrique Guedes Farias. "Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial". Revista de Saúde Pública 38, n.º 5 (outubro de 2004): 671–78. http://dx.doi.org/10.1590/s0034-89102004000500009.
Texto completo da fonteBalatif, Ridwan, Fadlan Hafizh Harahap e Isni Dhiyah Almira. "Recent Development on HIV Variants and HIV Vaccine". Cermin Dunia Kedokteran 49, n.º 12 (1 de dezembro de 2022): 687–92. http://dx.doi.org/10.55175/cdk.v49i12.328.
Texto completo da fonteKamboj, Sakshi, Siya Srivastava, Sana Siddiqui e Rohit Singh. "A WEB-BASED CROSS-SECTIONAL STUDY AMONG INDIANS REVEALS A WILLINGNESS SHIFT REGARDING COVID-19 VACCINE UPTAKE AFTER THE SECOND WAVE". Journal of Experimental Biology and Agricultural Sciences 9, n.º 5 (30 de outubro de 2021): 647–56. http://dx.doi.org/10.18006/2021.9(5).647.656.
Texto completo da fonteWang, Meicheng. "Dengue virus and vaccines: A review". Theoretical and Natural Science 15, n.º 1 (4 de dezembro de 2023): 292–98. http://dx.doi.org/10.54254/2753-8818/15/20240502.
Texto completo da fonteAuclair, Sarah, Lynn Soong e Haitao Hu. "Differential T follicular helper cell responses induced by candidate HIV vaccine strategies utilizing ALVAC versus Ad5 vectors". Journal of Immunology 200, n.º 1_Supplement (1 de maio de 2018): 125.22. http://dx.doi.org/10.4049/jimmunol.200.supp.125.22.
Texto completo da fonteKotaki, Tomohiro, Yurie Nagai, Atsushi Yamanaka, Eiji Konishi e Masanori Kameoka. "Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection". Vaccines 10, n.º 9 (28 de agosto de 2022): 1411. http://dx.doi.org/10.3390/vaccines10091411.
Texto completo da fonteBarouch, Dan H., Paul F. McKay, Shawn M. Sumida, Sampa Santra, Shawn S. Jackson, Darci A. Gorgone, Michelle A. Lifton et al. "Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines". Journal of Virology 77, n.º 16 (15 de agosto de 2003): 8729–35. http://dx.doi.org/10.1128/jvi.77.16.8729-8735.2003.
Texto completo da fonteTogoo, Khongorzul, Burenjargal Batmunkh, Nomin-Erdene Tsogtbayar, Ulziisaikhan Batmunkh, Enkhtuya Selenge, Khuselt-Od Togtokhbaatar, Gantuya Boldbaatar, Davaalkham Jagdagsuren, Batbaatar Gunchin e Tsogtsaikhan Sandag. "Antibody response of Comirnaty vaccine in different immunocompromised groups during the COVID-19 pandemic". Journal of Immunology 210, n.º 1_Supplement (1 de maio de 2023): 252.13. http://dx.doi.org/10.4049/jimmunol.210.supp.252.13.
Texto completo da fonteKrasnopolsky, Yu. "BIOTECHNOLOGICAL RESEARCH IN THE CREATION AND PRODUCTION OF ANTIRABIC VACCINES". Biotechnologia Acta 14, n.º 4 (agosto de 2021): 28–37. http://dx.doi.org/10.15407/biotech14.04.028.
Texto completo da fonteI, Rabiu. "COVID-19 Vaccine Hesitancy in Africa and Asian Continent: A Comparative Study Between Nigeria and Nepal". Vaccines & Vaccination Open Access 8, n.º 2 (4 de agosto de 2023): 1–8. http://dx.doi.org/10.23880/vvoa-16000166.
Texto completo da fonteCamara, Aichetou, Anaïs Razurel, Christelle Moreau, Thérésa Kwon, Marion Caseris, Olivier Bourdon e Sonia Prot-Labarthe. "P44 Vaccine in pediatric chronic kidney disease (CKD) and hemodialysis". Archives of Disease in Childhood 105, n.º 9 (19 de agosto de 2020): e29.2-e30. http://dx.doi.org/10.1136/archdischild-2020-nppg.53.
Texto completo da fonteTapia-Calle, Gabriela, Philip A. Born, Georgia Koutsoumpli, Martin Ignacio Gonzalez-Rodriguez, Wouter L. J. Hinrichs e Anke L. W. Huckriede. "A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro". Vaccines 7, n.º 4 (13 de novembro de 2019): 181. http://dx.doi.org/10.3390/vaccines7040181.
Texto completo da fonteWei, Yunhua, Yan Wang, Lin Liu, Yan Zha, Yuqi Yang, Yuanlin Wang, Neil Roberts e Yaying Li. "Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China". Vaccines 10, n.º 9 (2 de setembro de 2022): 1449. http://dx.doi.org/10.3390/vaccines10091449.
Texto completo da fonteGbaj, Abdul. "Mixing of Sputnik V and AstraZeneca COVID-19 vaccines". Clinical Research Notes 2, n.º 1 (6 de setembro de 2021): 01–03. http://dx.doi.org/10.31579/2690-8816/034.
Texto completo da fonte